Literature DB >> 22942272

Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: a 12-month follow-up study.

Ana Paula Bazanelli1, Maria Ayako Kamimura, Maria Eugenia Fernandes Canziani, Silvia Regina Manfredi, Lilian Cuppari.   

Abstract

OBJECTIVES: This prospective study, conducted at the dialysis unit of the Nephrology Division, Federal University of Sao Paulo-Oswaldo Ramos Foundation, Brazil, aimed to evaluate whether waist circumference (WC) can predict adiponectin levels in patients undergoing peritoneal dialysis (PD).
METHODS: Among 115 patients on PD at a single dialysis center who were evaluated at 6 and 12 months, 57% were men, 31% had diabetes, mean age was 52.8 ± 16.1 years, body mass index was 25 ± 4.3 kg/m(2), and dialysis vintage was 13 months (range: 5 - 33 months). We measured WC at the umbilicus level. Adiponectin was determined by an enzyme-linked immunosorbent assay.
RESULTS: At baseline, WC was inversely associated with adiponectin (r = -0.48, p < 0.01). After adjustment for sex, age, diabetes, peritoneal clearance, and residual renal function, WC was an independent determinant of serum adiponectin (β = -0.52; 95% confidence interval: -0.73 to -0.31; p < 0.001). In the prospective analysis, after adjustment for confounders, changes in WC predicted changes in adiponectin. For each unit increase in WC, adiponectin declined by 0.39 mg/L (p < 0.001).
CONCLUSIONS: This study demonstrates that WC is associated with adiponectin and, more importantly, that this simple marker of central adiposity was able to predict changes in adiponectin levels over time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22942272      PMCID: PMC3598108          DOI: 10.3747/pdi.2011.00129

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  37 in total

1.  Usefulness of waist circumference as a marker of abdominal adiposity in peritoneal dialysis: a cross-sectional and prospective analysis.

Authors:  Ana Paula Bazanelli; Maria Ayako Kamimura; Silvia Regina Manfredi; Sergio Antônio Draibe; Lilian Cuppari
Journal:  Nephrol Dial Transplant       Date:  2011-09-23       Impact factor: 5.992

2.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

Authors:  M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn
Journal:  Diabetologia       Date:  2003-04-10       Impact factor: 10.122

4.  Probability of middle-aged men developing coronary heart disease in five years.

Authors:  A Keys; C Aravanis; H Blackburn; F S Van Buchem; R Buzina; B S Djordjevic; F Fidanza; M J Karvonen; A Menotti; V Puddu; H L Taylor
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

5.  Usefulness of anthropometrics and dual-energy x-ray absorptiometry for estimating abdominal obesity measured by magnetic resonance imaging in older men and women.

Authors:  Kerry J Stewart; James R DeRegis; Katherine L Turner; Anita C Bacher; Jidong Sung; Paul S Hees; Edward P Shapiro; Matthew Tayback; Pamela Ouyang
Journal:  J Cardiopulm Rehabil       Date:  2003 Mar-Apr       Impact factor: 2.081

6.  Adiponectin in essential hypertension.

Authors:  Francesca Mallamaci; Carmine Zoccali; Fortunata Cuzzola; Giovanni Tripepi; Sebastiano Cutrupi; Saverio Parlongo; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Nephrol       Date:  2002 Sep-Oct       Impact factor: 3.902

7.  Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women.

Authors:  W-S Yang; M-H Chen; W-J Lee; K-C Lee; C-L Chao; K-C Huang; C-L Chen; T-Y Tai; L-M Chuang
Journal:  Int J Obes Relat Metab Disord       Date:  2003-08

8.  Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.

Authors:  Peter Stenvinkel; Alicia Marchlewska; Roberto Pecoits-Filho; Olof Heimbürger; Zhengzhong Zhang; Catherine Hoff; Cliff Holmes; Jonas Axelsson; Sivonne Arvidsson; Martin Schalling; Peter Barany; Bengt Lindholm; Louise Nordfors
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  Eur J Endocrinol       Date:  2002-08       Impact factor: 6.664

10.  Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function.

Authors:  Jenq-Wen Huang; Chung-Jen Yen; Hong-Wei Chiang; Kuan-Yu Hung; Tun-Jun Tsai; Kwan-Dun Wu
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

View more
  1 in total

Review 1.  Body composition in chronic kidney disease.

Authors:  Kirsten L Johansen; Carol Lee
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.